Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.

Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found batteries with an “extremely high failure rate.” Credit...Illustration by Mel ...

Durham authorities found no threat after getting a call about an active shooter at the North Carolina School of Science and Mathematics on Tuesday afternoon. The school enacted a lockdown for ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

A top White House economist dubbed the weekend report about artificial intelligence risks that had roiled the stock market “science fiction.” The paper from Citrini Research imagines a 2028 world in ...

NASA on Thursday released the results of its investigation into Boeing’s bungled 2024 flight to the International Space Station, which stranded two astronauts there for months. Subscribe to read this ...

Researchers in Turkey say they have unearthed archaeological evidence that the Romans used human feces in medical treatments. Although Roman texts described the practice, this is the first time that ...

LONDON, Feb 9 (Reuters) - Britain's WPP (WPP.L), opens new tab is preparing to bring its three main creative advertising agencies under one banner, the Financial Times reported on Monday, as its new ...

Senator Cynthia Lummis (R-Wyo.) on Thursday said the Senate Banking Committee pulled the crypto bill the day before a scheduled vote due to bank concerns about losing deposits, pushing the legislation ...

Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings ...

Feb 4 (Reuters) - Boston Scientific (BSX.N), opens new tab on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares ...